Many medicines get second shot when they have useful or desirable side effects. Dec. 29, 2008 — -- Some people might look at Meiko Catron, a native of Japan, and find her tilted eyes exotic and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. LONDON — Lumigan (AGN 192024, Allergan) once daily ...

The Food and Drug Administration has approved Amneal’s bimatoprost ophthalmic solution 0.01% (2.5 ml, 5 ml and 7.5 ml), which is the generic of Allergan’s Lumigan. Bimatoprost ophthalmic solution 0.01 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. NEW YORK — Phase 2 clinical trials of the glaucoma drug ...

Firm projects Lumigan product sales will total $490–$510 million in 2010. FDA has approved Allergan’s Lumigan® 0.01% bimatoprost solution as first-line therapy for reducing intraocular pressure (IOP) ...

In Allergan, Inc. v. Sandoz, Inc., the Federal Circuit affirmed the district court decision that upheld the validity of the Allergan patents relating to Lumigan® 0.01% glaucoma eye drops. This ...

SAN FRANCISCO Jan 14 (Reuters) - A Texas judge has upheld U.S. patents covering Allergan Inc's Lumigan glaucoma drug through 2027, the company said in a regulatory filing on Tuesday, helping to send ...

Eye drops used to treat glaucoma hold the key to a cure for baldness. Researchers have found bimatoprost, a key ingredient in the Lumigan drug, increases hair growth. The drug is given as eye drops to ...

Patent-cliff worries have been weighing on Allergan ($AGN) as of late, but a Texas judge has allayed some of those concerns--at least for now. That judge upheld U.S ...